GoldenGolden
Advanced Search
Mologic Ltd.

Mologic Ltd.

Company developing rapid diagnostic technologies, products and services in human healthcare, agriculture and aquaculture

Mologic develops lateral flow and rapid diagnostic technologies, products and services for human healthcare, agriculture and aquaculture. Co-Founder and CSO Paul Davis developed the Clearblue pregnancy test launched in 1988, which was the world’s first commercial application of lateral flow technology. Mologic offers device and reagent products for clinical and commercial applications and scientific research expertise for contract R&D.

Mologic is collaborating with the Senegalese research foundation Institut Paseur de Dakar to develop a 10 minute COVID-19 diagnostic test. The test will use technology from home pregnancy tests and malaria tests and offer a saliva and finger-prick blood test. In Africa the tests are planned to be manufactured in Senegal by DiaTropix, a diagnostics manufacturing facility led by Amandou Alpha Sall, director of the Pasteur Institute. Mologic and the Institut Pasteur have joint capacity to produce 8 million tests per year with plans to sell directly to African governments, the Global Alliance for Vaccines and Immunizations and the WHO. Mologic seeks a manufacturing facility to produce tests in the UK. Mologic received £1 million ($1.2 million) funding from the U.K. government for the development of the COVID-19 diagnostic test.

Timeline

October 2015
Mologic Ltd. raises a $3,900,000 venture round from Calculus Capital.
June 2, 2003
Mologic Ltd. was founded by Mark Davis and Paul Davis.

Funding rounds

People

Name
Role
LinkedIn

Paul Davis

Co-founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.